These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 22568822)

  • 1. Oncogenic transformation induced by cell-free nucleic acids circulating in plasma (genometastasis) remains after the surgical resection of the primary tumor: a pilot study.
    García-Olmo D; García-Olmo DC; Domínguez-Berzosa C; Guadalajara H; Vega L; García-Arranz M
    Expert Opin Biol Ther; 2012 Jun; 12 Suppl 1():S61-8. PubMed ID: 22568822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-free nucleic acids circulating in the plasma of colorectal cancer patients induce the oncogenic transformation of susceptible cultured cells.
    García-Olmo DC; Domínguez C; García-Arranz M; Anker P; Stroun M; García-Verdugo JM; García-Olmo D
    Cancer Res; 2010 Jan; 70(2):560-7. PubMed ID: 20068178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumorigenesis by transected cells in nude mice: a new method for detecting cellular transforming genes.
    Blair DG; Cooper CS; Oskarsson MK; Eader LA; Vande Woude GF
    Prog Clin Biol Res; 1983; 119():79-90. PubMed ID: 6346333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of oncogenic potentialities of human melanoma: identification of N-ras oncogene after DNA transfer and tumour induction.
    Jouanneau J; Bertrand S; Ducros E; Longuet M; Dore JF; Tavitian A
    In Vivo; 1987; 1(2):119-24. PubMed ID: 2979772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating nucleic acids in plasma/serum and tumor progression: are apoptotic bodies involved? An experimental study in a rat cancer model.
    Samos J; García-Olmo DC; Picazo MG; Rubio-Vitaller A; García-Olmo D
    Ann N Y Acad Sci; 2006 Sep; 1075():165-73. PubMed ID: 17108207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. K-ras mutational analysis of polyclonal colorectal cancers identifies uniclonal circulating tumor cells.
    Thebo JS; Senagore AJ; Krygier S; Luchtefeld MA
    Am Surg; 2001 Aug; 67(8):802-5. PubMed ID: 11510588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgery and hematogenous dissemination: comparison between the detection of circulating tumor cells and of tumor DNA in plasma before and after tumor resection in rats.
    García-Olmo DC; Gutiérrez-González L; Samos J; Picazo MG; Atiénzar M; García-Olmo D
    Ann Surg Oncol; 2006 Aug; 13(8):1136-44. PubMed ID: 16865589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistence of K-ras mutations in plasma after colorectal tumor resection.
    Lindforss U; Zetterquist H; Papadogiannakis N; Olivecrona H
    Anticancer Res; 2005; 25(1B):657-61. PubMed ID: 15816642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of protooncogenes in spontaneously occurring non-liver tumors from C57BL/6 x C3H F1 mice.
    Candrian U; You M; Goodrow T; Maronpot RR; Reynolds SH; Anderson MW
    Cancer Res; 1991 Feb; 51(4):1148-53. PubMed ID: 1997158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NIH-3T3 fibroblasts cultured with plasma from colorectal cancer patients generate poorly differentiated carcinomas in mice.
    Serrano-Heras G; Domínguez-Berzosa C; Collantes E; Guadalajara H; García-Olmo D; García-Olmo DC
    Cancer Lett; 2012 Mar; 316(1):85-90. PubMed ID: 22093615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transfer of a dominant-acting tumor-inducing oncogene from human prostatic carcinoma cells to cloned rat embryo fibroblast cells by DNA-transfection.
    Su ZZ; Olsson CA; Zimmer SG; Fisher PB
    Anticancer Res; 1992; 12(2):297-304. PubMed ID: 1580547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymerase chain reaction/sequencing analysis of ras mutations in paraffin-embedded tissues as compared with 3T3 transfection and polymerase chain reaction/sequencing of frozen tumor deoxyribonucleic acids.
    Goodrow TL; Prahalada SR; Storer RD; Manam SV; Leander KR; Kraynak AR; van Zwieten MJ; Nichols WW; Bradley MO
    Lab Invest; 1992 Apr; 66(4):504-11. PubMed ID: 1583889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P53 and K-ras mutations are frequent events in microscopically negative surgical margins from patients with nonsmall cell lung carcinoma.
    Jassem J; Jassem E; Jakóbkiewicz-Banecka J; Rzyman W; Badzio A; Dziadziuszko R; Kobierska-Gulida G; Szymanowska A; Skrzypski M; Zylicz M
    Cancer; 2004 May; 100(9):1951-60. PubMed ID: 15112277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection and identification of activated oncogenes in human skin cancers occurring on sun-exposed body sites.
    Ananthaswamy HN; Price JE; Goldberg LH; Bales ES
    Cancer Res; 1988 Jun; 48(12):3341-6. PubMed ID: 3370635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of K-ras by codon 13 mutations in C57BL/6 X C3H F1 mouse tumors induced by exposure to 1,3-butadiene.
    Goodrow T; Reynolds S; Maronpot R; Anderson M
    Cancer Res; 1990 Aug; 50(15):4818-23. PubMed ID: 2196119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Release of cell-free DNA into the bloodstream leads to high levels of non-tumor plasma DNA during tumor progression in rats.
    García-Olmo DC; Samos J; Picazo MG; Asensio AI; Toboso I; García-Olmo D
    Cancer Lett; 2008 Dec; 272(1):133-40. PubMed ID: 18707808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of disseminated tumour cells as a potential surrogate-marker for monitoring palliative chemotherapy in colorectal cancer patients.
    Staritz P; Kienle P; Koch M; Benner A; von Knebel Doeberitz M; Rudi J; Weitz J
    J Exp Clin Cancer Res; 2004 Dec; 23(4):633-9. PubMed ID: 15743034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. K-ras activation in neoplasms of the human female reproductive tract.
    Enomoto T; Inoue M; Perantoni AO; Terakawa N; Tanizawa O; Rice JM
    Cancer Res; 1990 Oct; 50(19):6139-45. PubMed ID: 2205377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smad7 but not Smad6 cooperates with oncogenic ras to cause malignant conversion in a mouse model for squamous cell carcinoma.
    Liu X; Lee J; Cooley M; Bhogte E; Hartley S; Glick A
    Cancer Res; 2003 Nov; 63(22):7760-8. PubMed ID: 14633701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Proteomic approach for protein-profiling the oncogenic ras induced transformation (H-, K-, and N-Ras) in NIH/3T3 mouse embryonic fibroblasts.
    Kim S; Lee YZ; Kim YS; Bahk YY
    Proteomics; 2008 Aug; 8(15):3082-93. PubMed ID: 18601226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.